ERBB2 and breast carcinoma: One example is that exosomes of HER2‐overexpressed breast cancer cells also contain HER2 molecules, which can be combined with the HER2 antibody drug trastuzumab, thus prevent the drug from binding to tumour cells and inhibit the anti‐tumour effects.155